Clinicopathological significance of BMP7 expression in esophageal squamous cell carcinoma

Annals of Surgical Oncology

Volumn 19, Issue 6, 2012, Pages 2066-2071

  Megumi, Koichi ^a   Ishigami, Sumiya ^a   Uchikado, Yasuto ^a   Kita, Yoshiaki ^a   Okumura, Hiroshi ^a   Matsumoto, Masataka ^a   Uenosono, Yoshikazu ^a   Arigami, Takaaki ^a   Kijima, Yuko ^a   Kitazono, Masaki ^a   Shinchi, Hiroyuki ^a   Ueno, Shinichi ^a   Natsugoe, Shoji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOGENIC PROTEIN 1;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; CYTOPLASM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BONE MORPHOGENETIC PROTEIN 7; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84865121292     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2024-5     Document Type: Article

References (35)

1. Patel SR, Dressler GR. BMP7 signaling in renal development and disease. Trends Mol Med. 2005;11:512-8. (Pubitemid 41653292)
2. Milan M. Sculpting a fly leg: BMP boundaries and cell death. Nat Cell Biol. 2007;9:17-8. (Pubitemid 46024190)
3. Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science. 2002;296:1646-7.
4. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev. 2005;19:2783-810. (Pubitemid 41739965)
5. Buijs JT, Rentsch CA, van Der Horst G, et al. BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Am J Pathol. 2007;171:1047-57. (Pubitemid 47441001)
6. Zeisberg EM, Tarnavski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature. 2007;13:952-61. (Pubitemid 47222040)
7. Alamo EL, Rauta J, Kallioniemi A, et al. Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer. Genes Chromosomes Cancer. 2006;45:411-9. (Pubitemid 43346773)
8. Miyazaki H, Watabe T, Kitamura T, Miyazono K. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells. Oncogene. 2004;23: 9326-35. (Pubitemid 40069665)
9. Beck SE, Jung BH, Del Rosario E, Gomez J, Carethers JM. BMP-induced growth suppression in colon cancer cells is mediated by p21(WAF1) stabilization and modulated by RAS/ERK. Cell Signal. 2007;19:1465-72. (Pubitemid 46818912)
10. Motoyama K, Tanaka F, Kosaka Y, et al. Clinical significance of BMP7 in human colorectal cancer. Ann Surg Oncol. 2008;15: 1530-36.
11. Sobin LH, Fleming ID. TNM classification of malignant tumors. 5th ed. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer. 1997;80:1803-4.
12. Wang SN, Lapage J, Hirschberg R. Loss of tubular bone mor-phogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol. 2001;12:2392-9. (Pubitemid 33021116)
13. Liu WI, Guo XZ, Zeng MS, et al. Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma. BMC Cancer. 2010;10:467.
14. Alarmo EL, Korhonen T, Huhtala H, et al. Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas. Ann Oncol. 2008;19:308-14. (Pubitemid 351201712)
15. Kwak C, Park YH, Kim IY, et al. Expression of bone morpho-genetic proteins, the subfamily of the transforming growth factor-b superfamily, in renal cell carcinoma. J Urol. 2007;178:1062-7. (Pubitemid 47211049)
16. Sulzbacher I, Birner P, Lang S, et al. The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter. J Clin Pathol. 2002;55:381-5. (Pubitemid 34494179)
17. Rothhammer T, Wild PJ, Bosserhoff AK, et al. Bone morpho-genetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma. Cancer Biomark. 2007;3:111-7. (Pubitemid 47103812)
18. Masuda H, Hukabori Y, Yamanaka H, et al. Expression of bone morphogenetic protein-7 (BMp-7) in human prostate. Prostate. 2004;59:101-6. (Pubitemid 38387847)
19. Alamo EL, Rauta J, Kallioniemi A, et al. Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer. Genes Chromosomes Cancer. 2006;45:411-9. (Pubitemid 43346773)
20. Aoki M, Ishigami S, Natugoe S, et al. Expression of BMP-7 in human gastric cancer and its clinical significance. Br J Cancer. 2011;104:714-8.
21. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442-54.
22. Peinado H, Quintanilla M, Cano A. Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem. 2003;278:21113-23. (Pubitemid 36806424)
23. Piek E, Moustakas A, Kurisaki A, et al. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesen-chymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci. 1999;112:4557-68. (Pubitemid 30034805)
24. Dudley AT, Lyons KM, Robertson EJ. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 1995;9:2795-807.
25. Luo G, Hofmann C, Bronckers AL, et al. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 1995;9:2808-20.
26. Vukicevic S, Kopp JB, Luyten FP, et al. Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). Proc Natl Acad Sci U S A 1996;93:9021-6. (Pubitemid 26282011)
27. Simic P, Vukicevic S. Bone morphogenetic proteins in development and homeostasis of kidney. Cytokine Growth Factor Rev. 2005;16:299-308. (Pubitemid 40910319)
28. Wang S, Hirschberg R. BMP7 antagonizes TGF-beta-dependent fibrogenesis in mesangial cells. Am J Physiol Renal Physiol. 2003;284:F1006-13.
29. Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nature. 2003;9:964-8. (Pubitemid 36889942)
30. Naitoh H, Shibata J, Hattori T, et al. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol. 1995;5:1161-9.
31. Natsugoe S, Xiangming C, Aikou T, et al. Smad4 and transforming growth factor b1 expression in patients with squamous cell carcinoma of the esophagus. Clin Cancer Res. 2002;8: 1838-42. (Pubitemid 34633743)
32. Chan KW, Lee PY, Srivastava G, et al. Clinical relevance of Fas expression in oesophageal squamous cell carcinoma. J Clin Pathol. 2006;59:101-4. (Pubitemid 43076247)
33. Takeno S, Noguchi T, M}uller W, et al. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer. 2002;94:2874-81. (Pubitemid 34547686)
34. Suzuki S, Miyazaki T, Kuwano H, et al. Prognostic significance of CD151 expression in esophageal squamous cell carcinoma with aggressive cell proliferation and invasiveness. Ann Surg Oncol. 2011;18:888-93.
35. Kita Y, Natsugoe S, Aikou T, et al. Expression of osteopontin in oesophageal squamous cell carcinoma. Br J Cancer. 2006;95: 634-8. (Pubitemid 44325904)